Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gene-tests could lead to osteoporosis treatment

This article was originally published in Clinica

Executive Summary

Genetic testing should lead to new approaches to osteoporosis prevention and treatment, according to researchers from St Thomas's Hospital, the United Medical and Dental School, London, and Garvan Institute, Sydney, Australia. Writing in the BMJ (May 27th), they say that bone density in post-menopausal British women - particularly the the hip and spine - is genetically linked and specifically associated with vitamin D receptor genotypes.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT091776

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel